Tuesday, March 8, 2016
1:30 – 2:45pm
Investing in Oncology – A New Math or Same Old Same Old?
- Mark Simon, Advisor, Torreya Partners
- John DeYoung, Vice President, Worldwide Business Development, Pfizer Inc.
- Richard Brian Gaynor, MD, Sr. Vice President Global Development / Medical Affairs, Oncology Business Unit, Eli Lilly and Company
- Axel Hoos, MD, PhD, Senior Vice President, Oncology R&D, GlaxoSmithKline
- David R. Parkinson, MD, Venture Partner, New Enterprise Associates, Inc.
- Ferran Prat, PhD, JD, Strategic Industry Ventures, The University of Texas MD Anderson Cancer Center